Theseus Pharmaceuticals Inc (THRX)

[surf1944]

7:36AM GlaxoSmithKline to increase its ownership in Theravance (THRX) (GSK) 19.50 : Co announced that they have entered into a stock purchase agreement, under which THRX will issue, and GSK will acquire, 10 mln shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212.8 mln Following this purchase, GSK would own ~25.8 mln shares of THRX common stock, which would increase GSK's ownership from ~18.3% to ~26.8% of the total outstanding capital stock of THRX.